Washington § 70.41.495 - Human immunodeficiency virus postexposure prophylaxis drugs and therapies — Policies — Coverage.

Full text of Washington Revised Code of Washington § 70.41.495 — Human immunodeficiency virus postexposure prophylaxis drugs and therapies — Policies — Coverage., with citation guidance and answers to common questions.

§ 70.41.495. Human immunodeficiency virus postexposure prophylaxis drugs and therapies — Policies — Coverage.

(1) A hospital must adopt a policy and have procedures in place, that conform with the guidelines issued by the centers for disease control and prevention, for the dispensing of human immunodeficiency virus postexposure prophylaxis drugs or therapies.
(2) This policy must ensure that hospital staff dispense or deliver as defined in RCW 18.64.011 to a patient, with a patient's informed consent, a 28-day supply of human immunodeficiency virus postexposure prophylaxis drugs or therapies following the patient's possible exposure to human immunodeficiency virus, unless medically contraindicated, inconsistent with accepted standards of care, or inconsistent with centers for disease control and prevention guidelines. When available, hospitals shall dispense or deliver generic human immunodeficiency virus postexposure prophylaxis drugs or therapies.
(3) Nothing in this section shall be construed to alter the coverage for reimbursement of postexposure prophylaxis drugs through:
(a) The crime victims' compensation program, established in chapter 7.68 RCW, for drugs dispensed or delivered to sexual assault victims; or
(b) The industrial insurance act for drugs dispensed or delivered to a worker exposed to the human immunodeficiency virus through the course of employment.
[ 2024 c 251 s 1.]

Notes

Effective date—2024 c 251: "This act takes effect January 1, 2025." [ 2024 c 251 s 6.]

Source: official Washington text · Last verified 2026-08-27

Related Washington Legal Topics

Frequently Asked Questions About Washington § 70.41.495

What does Revised Code of Washington § 70.41.495 cover?

Section 70.41.495 ("Human immunodeficiency virus postexposure prophylaxis drugs and therapies — Policies — Coverage.") is part of the Revised Code of Washington, the codified statutory law of Washington. It sets out the legal rule or procedure described in the text above. Statutes are amended regularly, so always verify against the official source.

How do I cite Washington § 70.41.495?

A common citation format is "Revised Code of Washington § 70.41.495" (Washington). Legal writing may require the code abbreviation, section number, and year or edition. Match the style required by your court, professor, or publisher.

Is this the official text of Washington law?

No. This page is for research and education and may not include the most recent amendments. For official current law, check the Washington official source linked on this page or consult a licensed Washington attorney.

How does Washington § 70.41.495 apply to my situation?

Statutes are interpreted in context, and application depends on your specific facts. Only a licensed attorney in Washington can advise on how this section applies to you. Contact your state or local bar association for a referral.

Sources & Verification

Not legal advice. Verify against the official source and consult a licensed attorney in Washington.